1. Home
  2. SBFM vs WAFU Comparison

SBFM vs WAFU Comparison

Compare SBFM & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBFM
  • WAFU
  • Stock Information
  • Founded
  • SBFM 2006
  • WAFU 1999
  • Country
  • SBFM United States
  • WAFU China
  • Employees
  • SBFM N/A
  • WAFU N/A
  • Industry
  • SBFM Biotechnology: Pharmaceutical Preparations
  • WAFU Other Consumer Services
  • Sector
  • SBFM Health Care
  • WAFU Real Estate
  • Exchange
  • SBFM Nasdaq
  • WAFU Nasdaq
  • Market Cap
  • SBFM 6.7M
  • WAFU 6.5M
  • IPO Year
  • SBFM N/A
  • WAFU 2019
  • Fundamental
  • Price
  • SBFM $1.75
  • WAFU $1.86
  • Analyst Decision
  • SBFM Strong Buy
  • WAFU
  • Analyst Count
  • SBFM 1
  • WAFU 0
  • Target Price
  • SBFM $7.00
  • WAFU N/A
  • AVG Volume (30 Days)
  • SBFM 71.9K
  • WAFU 218.1K
  • Earning Date
  • SBFM 11-04-2025
  • WAFU 01-01-0001
  • Dividend Yield
  • SBFM N/A
  • WAFU N/A
  • EPS Growth
  • SBFM N/A
  • WAFU N/A
  • EPS
  • SBFM N/A
  • WAFU N/A
  • Revenue
  • SBFM $36,341,741.00
  • WAFU $6,186,645.00
  • Revenue This Year
  • SBFM $32.20
  • WAFU N/A
  • Revenue Next Year
  • SBFM $32.74
  • WAFU N/A
  • P/E Ratio
  • SBFM N/A
  • WAFU N/A
  • Revenue Growth
  • SBFM 19.22
  • WAFU N/A
  • 52 Week Low
  • SBFM $1.17
  • WAFU $1.22
  • 52 Week High
  • SBFM $3.90
  • WAFU $7.49
  • Technical
  • Relative Strength Index (RSI)
  • SBFM 66.08
  • WAFU 52.87
  • Support Level
  • SBFM $1.50
  • WAFU $1.92
  • Resistance Level
  • SBFM $1.74
  • WAFU $2.10
  • Average True Range (ATR)
  • SBFM 0.09
  • WAFU 0.14
  • MACD
  • SBFM 0.01
  • WAFU -0.03
  • Stochastic Oscillator
  • SBFM 96.84
  • WAFU 18.42

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About WAFU Wah Fu Education Group Limited

Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions, and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.

Share on Social Networks: